Bloomage Biotechnology Corp Ltd
SSE:688363
Operating Margin
Bloomage Biotechnology Corp Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CN |
|
Bloomage Biotechnology Corp Ltd
SSE:688363
|
11.6B CNY |
1%
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
-17 527%
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
389B USD |
31%
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
152.1B USD |
31%
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
146.4B USD |
38%
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
-370%
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
101.8B USD |
39%
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
101.2B AUD |
26%
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
61.4B USD |
-7%
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
60.5B USD |
29%
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
40.1B EUR |
15%
|
Bloomage Biotechnology Corp Ltd
Glance View
Nestled in the bustling corridors of the biotechnology industry, Bloomage Biotechnology Corp Ltd. has carved a niche as a leading player specializing in the production and innovation of biopolymers, with a particular emphasis on hyaluronic acid. Since its inception, the company has embraced a scientific approach combined with a robust business strategy, propelling it to the forefront of biotechnological advancements. Its operations are underpinned by a relentless pursuit of research and development, utilizing cutting-edge fermentation technology to manufacture high-quality hyaluronic acid that serves various industries such as cosmetics, food, and pharmaceuticals. Bloomage’s revenue model is intricately linked to the diverse applications of hyaluronic acid. By supplying raw materials to cosmetic giants, the company significantly taps into the lucrative beauty industry, as this compound is highly valued for its skin hydration properties. Additionally, Bloomage is involved in the healthcare segment, where it provides key ingredients for medical products that enhance joint health and accelerate wound healing. Through strategic partnerships and a focus on high-margin products, Bloomage not only diversifies its revenue streams but also sustains its position in competitive markets. This deliberate orchestration of science and commerce ensures the company remains at the vanguard of both innovation and profitability.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Bloomage Biotechnology Corp Ltd's most recent financial statements, the company has Operating Margin of 1.1%.
You don't have any saved screeners yet